Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.67	86.1	21.99	15.57	104.92
Short-Term Investments	428.5	232.3	329.95	265.22	24.18
Cash & Short-Term Investments	470.17	318.39	351.95	280.79	129.09
Cash Growth	47.67%	-9.53%	25.34%	117.51%	445.78%
Prepaid Expenses	5.31	8.6	5.05	2.98	0.55
Total Current Assets	475.48	327	357	283.77	129.65
Property, Plant & Equipment	11.07	12.69	9.85	0.91	0.52
Long-Term Deferred Charges	0.26	0.3	0.25	-	0.7
Other Long-Term Assets	-	0.05	-	0.55	0.28
Total Assets	486.82	340.04	367.1	285.23	131.14
Accounts Payable	5.58	4.03	6.11	3.84	1.58
Accrued Expenses	17.29	11.77	9.87	6.68	2.31
Current Portion of Leases	1	0.98	0.61	-	-
Other Current Liabilities	-	-	-	-	0.45
Total Current Liabilities	23.86	16.77	16.59	10.52	4.34
Long-Term Leases	3.74	4.43	3.8	-	-
Other Long-Term Liabilities	-	-	-	0.33	-
Total Liabilities	27.6	21.21	20.39	10.85	4.34
Common Stock	0.01	0.01	0.01	0.01	-
Additional Paid-In Capital	837.36	563.49	492.67	351.85	0.73
Retained Earnings	-378.58	-244.76	-144.6	-76.96	-34.15
Comprehensive Income & Other	0.42	0.1	-1.36	-0.51	-
Total Common Equity	459.22	318.83	346.72	274.38	-33.42
Shareholders' Equity	459.22	318.83	346.72	274.38	126.79
Total Liabilities & Equity	486.82	340.04	367.1	285.23	131.14
Total Debt	4.74	5.41	4.41	-	-
Net Cash (Debt)	465.43	312.98	347.54	280.79	129.09
Net Cash Growth	48.71%	-9.94%	23.77%	117.51%	445.78%
Net Cash Per Share	5.04	4.91	6.48	7.48	174.69
Filing Date Shares Outstanding	95.21	93.11	63.26	49.51	1.01
Total Common Shares Outstanding	94.84	70.45	63.26	49.5	1.01
Working Capital	451.62	310.23	340.41	273.25	125.3
Book Value Per Share	4.84	4.53	5.48	5.54	-33.11
Tangible Book Value	459.22	318.83	346.72	274.38	-33.42
Tangible Book Value Per Share	4.84	4.53	5.48	5.54	-33.11
Machinery	4.54	4.25	2.26	1.61	-
Construction In Progress	-	0.08	7.34	-	-
Leasehold Improvements	9.65	8.73	-	-	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q